Judi Jehle, MD
Gynecology · Montgomery, ALNPI 1487743761
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.2% of the total across 229 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Among gynecology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 229 payments — averaging $20.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$909
- Radius Health, Inc.$746
- Astellas Pharma US Inc$485
- Amgen$415
- Sumitomo Pharma America, Inc.$343
- Pfizer$277
- plus $1K from 29 others
What the payments were for
- Food & beverage$4,34393%
- Education$3197%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $909 |
| Radius Health, Inc. | 31 | $746 |
| Astellas Pharma US Inc | 15 | $485 |
| Amgen | 22 | $415 |
| Sumitomo Pharma America, Inc. | 21 | $343 |
| Pfizer | 16 | $277 |
| Hologic Sales And Service, LLC | 9 | $151 |
| Therapeuticsmd, Inc. | 7 | $115 |
| Medtronic(2 entities) | 4 | $111 |
| Millicent US Inc | 5 | $110 |
| Myovant Sciences Inc. | 6 | $89 |
| Mayne Pharma Commercial LLC | 5 | $87 |
| Aspira Women's Health Inc | 1 | $84 |
| Bayer | 5 | $70 |
| Mylan Pharmaceuticals Inc. | 5 | $64 |
| Novo Nordisk | 3 | $61 |
| Exact Sciences | 3 | $49 |
| Axonics, Inc. | 3 | $49 |
| Duchesnay USA Incorporated | 3 | $47 |
| Scynexis, Inc. | 3 | $45 |
| Organon | 2 | $43 |
| Dexcom, Inc. | 2 | $38 |
| Exeltis, USA Inc. | 2 | $36 |
| Urovant Sciences Inc | 2 | $32 |
| Avion Pharmaceuticals | 2 | $28 |
| Shield Therapeutics Inc | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Monaghan Medical Corporation | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Minerva Surgical, Inc | 1 | $15 |
| Meditrina | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$102
How this compares
$4,662 in reported general payments places this provider in the 90th percentile of 51 gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 44 | $27,862 |
| MyrbetriqMirabegron | 31 | $18,916 |
| Estradiol | 234 | $17,752 |
| PremarinEstrogens, Conjugated | 26 | $12,284 |
| LinzessLinaclotide | 19 | $11,600 |
| Estradiol (Twice Weekly)Estradiol | 25 | $3,899 |
| DottiEstradiol | 18 | $3,565 |
| YuvafemEstradiol | 17 | $3,282 |
| ValacyclovirValacyclovir Hcl | 42 | $1,932 |
| Raloxifene Hcl | 13 | $1,872 |
| Acyclovir | 23 | $1,269 |
| Solifenacin Succinate | 17 | $902 |
| Nystatin | 65 | $863 |
| Bupropion XlBupropion Hcl | 12 | $675 |
| Betamethasone Valerate | 26 | $662 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $343 | $27,86244 claims |
| Astellas Pharma US IncMyrbetriq | $485 | $18,91631 claims |
| PfizerPremarin | $277 | $12,28426 claims |
| AbbVieLinzess | $909 | $11,60019 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 51 gynecology providers in Alabama.
Other gynecology in Montgomery
- James DockeryMontgomery$6K
- John PorterMontgomery$5K
- Joe McClintonMontgomery$1K
- Hajrunisa CubroMontgomery$1K
- Arthur BrittonMontgomery$274
- Stuart MayMontgomery$127
- Holly RichterBirmingham$22K
- Alex ChildsBirmingham$9K
- Gena DunivanBirmingham$7K
- Glenn GallaspyMobile$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.